Results 91 to 100 of about 1,088,075 (297)

Research advances on Golgi stress response in bone metabolism

open access: yesKouqiang hemian waike zazhi
During the growth, development, and injury repair processes of mammals, organelles undergo self-regulation through a series of complex regulatory mechanisms when subjected to interference from inside or outside, in order to maintain cellular homeostasis.
NIU Pingping, SUN Yao
doaj   +1 more source

Differential Compartmentalization of Enzymatic Reactions for Lactate Signaling Across Protocells

open access: yesAdvanced Functional Materials, EarlyView.
Two populations of protocells consisting of giant unilamellar vesicles containing active species and distinct artificial organelles are competent of collective behavior by mimicking production, intercellular communication, and detection of the bioinspired signal molecule lactate. Enzymatic cascade reactions within artificial organelles demonstrate that
Arianna Balestri   +4 more
wiley   +1 more source

Subcellular Performance of Nanoparticles in Cancer Therapy

open access: yesInternational Journal of Nanomedicine, 2020
Chen-Guang Liu, 1, 2,* Ya-Hui Han, 1, 2,* Ranjith Kumar Kankala, 1–3 Shi-Bin Wang, 1–3 Ai-Zheng Chen 1–3 1Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen, Fujian 361021, People’s Republic of China ...
Liu CG   +4 more
doaj  

Metal Nanoclusters for Cancer Imaging and Treatment

open access: yesAdvanced Functional Materials, EarlyView.
This review aims to provide a comprehensive summary and discussion of the core–shell design capabilities of metal nanoclusters (NCs) at the atomic level for cancer imaging and treatment. It offers essential insights into the design principles of metal NCs while also encouraging the exploration of other nanomaterials and their potential theranostic ...
Haiguang Zhu   +5 more
wiley   +1 more source

Organelle Inheritance [PDF]

open access: yesCell, 1996
Warren, Graham, Wickner, William
openaire   +2 more sources

Antibody‐Programmable Bimetallic Nanozymes for Transcriptional Blockade Therapy in HER2/ER‐Positive Breast Cancer

open access: yesAdvanced Functional Materials, EarlyView.
Zr‐Fe MOF@Ribociclib@Herceptin (ZFRH) efficiently targets/kills Human Epidermal Growth Factor Receptor 2/Estrogen Receptor‐positive (HER2/ER+) breast cancer cells. It combats tumors by: 1) Elevating ROS, altering redox balance; 2) Inhibiting transcription; 3) Inducing pyroptosis.
Hongkun Miao   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy